BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 11391725)

  • 1. Erythroleukemia following erythropoietin therapy, extramedullary hematopoiesis, and splenectomy in a patient with myelofibrosis and myeloid metaplasia.
    Coleman TA; Hamill RL; Ford SM
    Am J Hematol; 2001 Jul; 67(3):214-5. PubMed ID: 11391725
    [No Abstract]   [Full Text] [Related]  

  • 2. The spleen in myeloproliferative disorders.
    Goldman JM; Nolasco I
    Clin Haematol; 1983 Jun; 12(2):505-16. PubMed ID: 6352114
    [No Abstract]   [Full Text] [Related]  

  • 3. [Splenic extramedullary hematopoiesis in myelofibrosis. Pathogenetic considerations apropos of a personally studied case].
    Piaserico PL; Piaserico GP
    Minerva Med; 1983 Oct; 74(39):2313-8. PubMed ID: 6657100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extramedullary hematopoiesis involving the esophagus in myelofibrosis.
    Fedeli G; Certo M; Cannizzaro O; Forti G; Perniola R; Manna R; Gambassi G
    Am J Gastroenterol; 1990 Nov; 85(11):1512-4. PubMed ID: 2239880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia.
    Petroianu A
    Int Surg; 1996; 81(2):177-9. PubMed ID: 8912088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks and benefits of splenectomy in myelofibrosis: an analysis of 39 cases.
    Lafaye F; Rain JD; Clot P; Najean Y
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):359-62. PubMed ID: 7892130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of cutaneous extramedullary hematopoiesis associated with idiopathic myelofibrosis].
    Corella F; Barnadas MA; Bordes R; Curell R; Espinosa I; Vergara C; Alomar A
    Actas Dermosifiliogr; 2008 May; 99(4):297-300. PubMed ID: 18394406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic irradiation in myelofibrosis with myeloid metaplasia: a review.
    Elliott MA; Tefferi A
    Blood Rev; 1999 Sep; 13(3):163-70. PubMed ID: 10527268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Massive hepatomegaly following splenectomy for myeloid metaplasia.
    Grieco A; Manna R; Mancini R; Gambassi G
    Am J Med; 1988 Apr; 84(4):797. PubMed ID: 3400674
    [No Abstract]   [Full Text] [Related]  

  • 10. Splenectomy for massive splenomegaly.
    Coon WW
    Surg Gynecol Obstet; 1989 Sep; 169(3):235-7. PubMed ID: 2772794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wild-type JAK2 secondary acute erythroleukemia developing after JAK2-V617F-mutated primary myelofibrosis.
    Kreft A; Springer E; Lipka DB; Kirkpatrick CJ
    Acta Haematol; 2009; 122(1):36-8. PubMed ID: 19713696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPLENECTOMY FOR MARKED SPLENOMEGALY DUE TO EXTRAMEDULLARY HEMATOPOIESIS.
    SNYDER H
    Med Rec Ann; 1964 Jan; 57():277-8. PubMed ID: 14115110
    [No Abstract]   [Full Text] [Related]  

  • 13. Agnogenic myeloid metaplasia; its current managment.
    Silverstein MN
    Minn Med; 1970 Mar; 53(3):257-9. PubMed ID: 5415744
    [No Abstract]   [Full Text] [Related]  

  • 14. Esophageal varices in agnogenic myeloid metaplasia: disappearance after splenectomy. A case report.
    Sullivan A; Rheinlander H; Weintraub LR
    Gastroenterology; 1974 Mar; 66(3):429-32. PubMed ID: 4813509
    [No Abstract]   [Full Text] [Related]  

  • 15. Splenectomy for agnogenic myeloid metaplasia.
    Coon WW; Liepman MK
    Surg Gynecol Obstet; 1982 Apr; 154(4):561-3. PubMed ID: 7064091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Massive splenomegaly and extramedullary hematopoiesis in chronic idiopathic myelofibrosis.
    Montague N; De La Ossa M
    Blood; 2010 Oct; 116(14):2410. PubMed ID: 20949696
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of splenectomy on teardrop-shaped erythrocytes in agnogenic myeloid metaplasia.
    DiBella NJ; Silverstein MN; Hoagland HC
    Arch Intern Med; 1977 Mar; 137(3):380-1. PubMed ID: 843155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional and experimental drug therapy in myelofibrosis with myeloid metaplasia.
    Mesa RA; Quintás-Cardama A; Verstovsek S
    Curr Hematol Malig Rep; 2007 Feb; 2(1):25-33. PubMed ID: 20425385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune haemolytic anaemia as the presenting manifestation of agnogenic myeloid metaplasia.
    Mohite U; Pathare A; al Kindi S; Hiwase D; Vadakkepat N; Knox-Macaulay H
    Haematologia (Budap); 2002; 32(4):495-9. PubMed ID: 12803124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palliative splenectomy in myelofibrosis with myeloid metaplasia.
    Mesa RA; Tefferi A
    Leuk Lymphoma; 2001; 42(5):901-11. PubMed ID: 11697645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.